NCT03615755View on ClinicalTrials.gov

Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 27, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Hyperbaric Oxygen TherapyDiabetic Foot UlcerType II Diabetes Mellitus
Interventions
OTHER

Hyperbaric Oxygen Therapy (HBOT)

The investigators used 10 sessions of HBOT. One session of HBOT uses oxygen at 2.4 ATA for 90 minutes per day at multiplace hyperbaric chamber. This therapy is given five sessions in a week, so it takes two weeks.

All Listed Sponsors
lead

Hendry Irawan

OTHER

NCT03615755 - Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine | Biotech Hunter | Biotech Hunter